WTWei-Jie Tian

Wei-Jie Tian

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Wei-Jie Tian has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Dong-Lin Li

    Department of Gynecology, Guizhou Provincial People’s Hospital, Medical College of Guizhou University

    1 shared publication
  • Jun Wang

    Department of Gynecology, Guizhou Provincial People’s Hospital, Medical College of Guizhou University, Guiyang, China

    1 shared publication
  • Peng-Hui Feng

    Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences

    1 shared publication
  • Qing-Feng Qin

    Department of Gynecology, Guizhou Provincial People’s Hospital, Medical College of Guizhou University

    1 shared publication
  • Ting Yan

    Department of Gynecology, Guizhou Provincial People’s Hospital, Medical College of Guizhou University, Guiyang, China

    1 shared publication
  • Wen-Tong Liang

    Department of Gynecology, Guizhou Provincial People’s Hospital, Medical College of Guizhou University

    1 shared publication

Latest Publications

  • Open Access

    CCR7 Has Potential to Be a Prognosis Marker for Cervical Squamous Cell Carcinoma and an Index for Tumor Microenvironment Change

    by Wei-Jie Tian, Peng-Hui Feng, Jun Wang, Ting Yan, Qing-Feng Qin, Dong-Lin Li, Wen-Tong Liang

    The tumor microenvironment (TME) has an essential role in the development of cervical squamous cell carcinoma (CSCC); however, the dynamic role of the stromal and immune cells is still unclear in TME. We downloaded data from The Cancer Genome Atlas (TCGA) database and applied ESTIMATE and CIBERSORT algorithms to measure the quantity of stromal and immune cells and the composition of tumor-infiltrating immune cell (TIC) in 253 CSCC cases. The protein-protein interaction (PPI) network and Cox regression analysis presented the differentially expressed genes (DEGs). Then, C-C chemokine receptor type 7 (CCR7) was screened out as a prognostic marker by the univariate Cox and intersection analysis of PPI. Further analysis showed a positive correlation between the expression of CCR7 and the survival of CSCC patients. The result of the Gene Set Enrichment Analysis (GSEA) of genes in the high CCR7 expression group displayed a predominant enrichment in immune-related pathways. An enrichment in metabolic activities was observed in the low CCR7 expression group. CIBERSORT analysis showed a positive correlation between Plasma cells, CD8+ T cells, and regulatory T cells and the CCR7 expression, suggesting that CCR7 might play a crucial role in maintaining the immunological dominance status for TME. Therefore, the expression level of CCR7 might help predict the survival of CSCC cases and be an index that the status of TME transitioned from immunological dominance to metabolic activation, which presented a new insight into the treatment of CSCC.


  • Open Access

    The effects of progesterones on blood lipids in hormone replacement therapy

    by Yifan Jiang, Weijie Tian

    The safety of progestogens as a class has drawn much attention after the publication of data from the Women’s Health Initiative (WHI) trial, particularly with respect to cardiovascular disease. Depending on the chemical structure, pharmacokinetics, receptor affinity and potency of action, progestogens have a divergent range of properties that may translate to very different clinical effects. The purpose of this review is to describe the role of varied progestogens in hormone replacement therapy (HRT), especially focusing on blood lipids, which are the most important parameters for assessing cardiovascular disease risk.